202 related articles for article (PubMed ID: 32492789)
1. Effect of Omega-3 Polyunsaturated Fatty Acids Treatment on Lipid Pattern of HIV Patients: A Meta-Analysis of Randomized Clinical Trials.
Fogacci F; Strocchi E; Veronesi M; Borghi C; Cicero AFG
Mar Drugs; 2020 Jun; 18(6):. PubMed ID: 32492789
[TBL] [Abstract][Full Text] [Related]
2. Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
Marston NA; Giugliano RP; Im K; Silverman MG; O'Donoghue ML; Wiviott SD; Ference BA; Sabatine MS
Circulation; 2019 Oct; 140(16):1308-1317. PubMed ID: 31530008
[TBL] [Abstract][Full Text] [Related]
3. The effect of n-3 polyunsaturated fatty acids on plasma lipids and lipoproteins in patients with chronic renal failure--a meta-analysis of randomized controlled trials.
Pei J; Zhao Y; Huang L; Zhang X; Wu Y
J Ren Nutr; 2012 Nov; 22(6):525-32. PubMed ID: 22698988
[TBL] [Abstract][Full Text] [Related]
4. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
[TBL] [Abstract][Full Text] [Related]
5. Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis.
Barkas F; Nomikos T; Liberopoulos E; Panagiotakos D
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823643
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
7. Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy: a randomized prospective study.
De Truchis P; Kirstetter M; Perier A; Meunier C; Zucman D; Force G; Doll J; Katlama C; Rozenbaum W; Masson H; Gardette J; Melchior JC
J Acquir Immune Defic Syndr; 2007 Mar; 44(3):278-85. PubMed ID: 17179770
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
Hartweg J; Perera R; Montori V; Dinneen S; Neil HA; Farmer A
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD003205. PubMed ID: 18254017
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia.
Pirillo A; Catapano AL
Atheroscler Suppl; 2013 Aug; 14(2):237-42. PubMed ID: 23958479
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia: A systematic review and meta-analysis.
Choi HD; Chae SM
Medicine (Baltimore); 2018 Dec; 97(50):e13593. PubMed ID: 30558030
[TBL] [Abstract][Full Text] [Related]
11. Effect of low-ratio n-6/n-3 PUFA on blood lipid level: a meta-analysis.
Li N; Jia M; Deng Q; Wang Z; Huang F; Hou H; Xu T
Hormones (Athens); 2021 Dec; 20(4):697-706. PubMed ID: 33123975
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.
Hartweg J; Farmer AJ; Perera R; Holman RR; Neil HA
Diabetologia; 2007 Aug; 50(8):1593-602. PubMed ID: 17541540
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials.
Ju J; Li J; Lin Q; Xu H
Phytomedicine; 2018 Nov; 50():25-34. PubMed ID: 30466986
[TBL] [Abstract][Full Text] [Related]
14. Effects of eicosapentaenoic acid and docosahexaenoic acid versus α-linolenic acid supplementation on cardiometabolic risk factors: a meta-analysis of randomized controlled trials.
Chen H; Deng G; Zhou Q; Chu X; Su M; Wei Y; Li L; Zhang Z
Food Funct; 2020 Mar; 11(3):1919-1932. PubMed ID: 32175534
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acid ethyl esters improve low-density lipoprotein subclasses without increasing low-density lipoprotein-cholesterol levels: A phase 4, randomized study.
Masuda D; Miyata Y; Matsui S; Yamashita S
Atherosclerosis; 2020 Jan; 292():163-170. PubMed ID: 31809985
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acid supplementation on lipid profiles in dialysis patients: meta-analysis.
Chi H; Lin X; Huang H; Zheng X; Li T; Zou Y
Arch Med Res; 2014 Aug; 45(6):469-77. PubMed ID: 25010561
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Omega-3 Polyunsaturated Fatty Acids Supplementation in Managing Overweight and Obesity: A Meta-Analysis of Randomized Clinical Trials.
Zhang YY; Liu W; Zhao TY; Tian HM
J Nutr Health Aging; 2017; 21(2):187-192. PubMed ID: 28112774
[TBL] [Abstract][Full Text] [Related]
18. Effects of dietary saturated and n-6 polyunsaturated fatty acids on the incorporation of long-chain n-3 polyunsaturated fatty acids into blood lipids.
Dias CB; Wood LG; Garg ML
Eur J Clin Nutr; 2016 Jul; 70(7):812-8. PubMed ID: 26757835
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia.
Barter P; Ginsberg HN
Am J Cardiol; 2008 Oct; 102(8):1040-5. PubMed ID: 18929706
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
Downie LE; Ng SM; Lindsley KB; Akpek EK
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
